Forma 063 O Blank Skachat
CLICK HERE ->>->>->> https://urlin.us/2tl7ZI
It is critical that applicants follow the instructions in the SF424 (R&R) Application Guide, includingSupplemental Instructions to the SF424 (R&R) for Preparing an Individual Research Career Development Award (CDA) Application ("K" Series), except where instructed to do otherwise (in this FOA or in a Notice from the NIH Guide for Grants and Contracts). Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions. Applications that do not comply with these instructions may be delayed or not accepted for review.
The overall goal of the NIH Research Career Development program is to help ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address the Nation's biomedical, behavioral, and clinical research needs. In addition to this opportunity, NIH Institutes and Centers (ICs) support a variety of other mentored career development programs designed to foster the transition of new investigators to research independence. These other programs may be more suitable for particular candidates. NIH also supports non-mentored career development programs for independent investigators.More information about Career programs may be found at the NIH Extramural Training Mechanisms website.
It is critical that applicants follow the instructions in the SF424 (R&R) Application Guide, including Supplemental Grant Application Instructions except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.
Candidates must carefully follow the SF424 (R&R) Application Guide, including the time period for when letters of reference will be accepted (letters are due by the application due date as described in the NOT-OD-11-079). At least three (3) but not more than five (5) reference letters should be provided by individuals not directly involved in the application. Applications lacking the appropriate required reference letters will not be reviewed. This is a separate process from submitting an application electronically. Reference letters are submitted directly through the eRA Commons Submit Referee Information link and not through Grants.gov.
Part I. Overview Information contains information about Key Dates. Applicants are encouraged to submit applications before the due date to ensure they have time to make any application corrections that might be necessary for successful submission.
For research that involves human subjects and meets the criteria for one or more of the six categories of research that are exempt under 45 CFR Part 46, the committee will evaluate: (1) the justification for the exemption, (2) human subjects involvement and characteristics, and (3) sources of materials. For additional information on review of the Human Subjects section, please refer to the Guidelines for the Review of Human Subjects.
The committee will evaluate the involvement of live vertebrate animals as part of the scientific assessment according to the following five points: (1) proposed use of the animals, and species, strains, ages, sex, and numbers to be used; (2) justifications for the use of animals and for the appropriateness of the species and numbers proposed; (3) adequacy of veterinary care; (4) procedures for limiting discomfort, distress, pain and injury to that which is unavoidable in the conduct of scientifically sound research including the use of analgesic, anesthetic, and tranquilizing drugs and/or comfortable restraining devices; and (5) methods of euthanasia and reason for selection if not consistent with the AVMA Guidelines on Euthanasia. For additional information on review of the Vertebrate Animals section, please refer to the Worksheet for Review of the Vertebrate Animal Section.
Reviewers will assess the information provided in this section of the application, including (1) the Select Agent(s) to be used in the proposed research, (2) the registration status of all entities where Select Agent(s) will be used, (3) the procedures that will be used to monitor possession use and transfer of Select Agent(s), and (4) plans for appropriate biosafety, biocontainment, and security of the Select Agent(s).
There will not be a formal Notice of Award (NoA) for applications until an institution has been identified by the candidate and approved by the NCI. The National Cancer Institute (NCI) will initially notify candidates who have successfully competed for funding with a Letter of Intent to Commit Funds. Candidates will then have up to 12 months from the date of the letter to accept an appointment in a domestic academic institution that has offered a position at the Assistant Professor level or an equivalent tenure-track faculty position (e.g., Assistant Member, Laboratory Head, Principal Investigator, etc.), at which the candidate is expected to establish his/her own independent research program, prepare applications for regular (non-career development) research project funding, and act as a PI(s)/PD(s) on such independent research projects.
Awardees must comply with any funding restrictions described in Section IV.5. Funding Restrictions. Selection of an application for award is not an authorization to begin performance. Any costs incurred before receipt of the NoA are at the recipient's risk. These costs may be reimbursed only to the extent considered allowable pre-award costs.
All NIH grant and cooperative agreement awards include the NIH Grants Policy Statement as part of the NoA. For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General and Part II: Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Grantees, and Activities. More information is provided at Award Conditions and Information for NIH Grants. More specifically, for K Awards, visit the Research Career Development ("K") Awardees section of the NIH Grants Policy Statement.
The Federal Funding Accountability and Transparency Act of 2006 (Transparency Act), includes a requirement for awardees of Federal grants to report information about first-tier subawards and executive compensation under Federal assistance awards issued in FY2011 or later. All awardees of applicable NIH grants and cooperative agreements are required to report to the Federal Subaward Reporting System (FSRS) available at www.fsrs.gov on all subawards over $25,000. See the NIH Grants Policy Statement for additional information on this reporting requirement.
In carrying out its stewardship of human resource-related programs, the NIH may request information essential to an assessment of the effectiveness of this program from databases and from participants themselves. Participants may be contacted after the completion of this award for periodic updates on various aspects of their employment history, publications, support from research grants or contracts, honors and awards, professional activities, and other information helpful in evaluating the impact of the program.
There are two types of PDF forms: fillable and static. Fillable PDF Forms can be filled in online and then printed. Static PDF Forms can be printed and information can be handwritten or typed on the paper copy. To view, complete and print PDF forms you will need the freely available Adobe Acrobat Reader software installed on your computer.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Every labor organization subject to the Labor-Management Reporting and Disclosure Act, as amended (LMRDA), the Civil Service Reform Act (CSRA) standards of conduct regulations, or the Foreign Service Act (FSA) must file an initial Form LM-1 Information Report, along with its constitution and bylaws, and an annual financial report, Forms LM-2, LM-3, or LM-4 Labor Organization Annual Report.
If you would like to receive via email periodic updates from OLMS, including information about the Form LM-2, enforcement results, and compliance assistance programs, you may subscribe to the OLMS Mailing List here.
To apply for a patent under 35 U.S.C. 111, transfer the ownership of a patent, or request other actions related to patents, certain information specified in the Patent Laws (Title 35, United States Code) and Rules (Title 37, Code of Federal Regulations) must be submitted to the U.S. Patent and Trademark Office (USPTO). The USPTO provides patent forms to the public to use in certain situations, but, in almost all situations the USPTO does not require use of a form, or even provide a form, to submit the information required. The patent forms provided below were designed as a guide to assist patent applicants and patentees in making certain limited submissions to the USPTO. Use of the patent forms for purposes they were not designed for is not advised. The Patent Laws and Rules should be your primary guide to what information must be submitted and how it must be submitted. Any submission that meets all requirements of the Patent Laws, Rules, and Orders and Notices of the Director of the US Patent and Trademark Office, will be accepted, whether or not it is similar to any of the patent forms provided below. A submission may not be accepted, even if it is identical to a patent form provided below, if in a specified case, it does not meet all the requirements of Patent Laws, Rules, and Orders and Notices. For current fee amounts, see the appropriate sections of the Patent Rules. A surcharge will be due if the basic filing fee is not paid on filing. Other consequences may occur if the proper fees are not paid or if the required action is not taken. 59ce067264
https://www.mmgreatadv.com/group/mysite-200-group/discussion/3a4a4158-6467-4ef6-b4be-2304550ef3f5